Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Autor: Andus, Tilo, Kocjan, Andreas, Müser, Moritz, Baranovsky, Andrey, Mikhailova, Tatyana L., Zvyagintseva, Tatyana D., Dorofeyev, Andrey E., Lozynskyy, Yurii S., Cascorbi, Ingolf, Stolte, Manfred, Vieth, Michael, Dilger, Karin, Mohrbacher, Ralf, Greinwald, Roland
Zdroj: Inflammatory Bowel Diseases; Nov2010, Vol. 16 Issue 11, p1947-1956, 10p
Databáze: Complementary Index
Externí odkaz: